|
Characteristics of the Mapou cohort population tested in 2000 and 2001 |
|||||||||||
| 2000 |
2001 |
||||||||||
| Variable |
N tested |
N (%) positive |
Mean |
SD |
N tested |
N (%) positive |
Mean |
SD |
p-value |
||
|
|
|||||||||||
| Gender (female) |
161 |
87 |
(54.0%) |
- |
0.50 |
- |
- |
- |
- |
- |
|
| Age (years) |
160 |
- |
24.7 |
19.52 |
- |
- |
- |
- |
- |
||
| Antigen + |
160 |
24 |
(15.0%) |
- |
0.36 |
161 |
14 |
(8.7%) |
- |
0.28 |
0.004 |
| Microfilaremic |
161 |
1 |
(0.6%) |
1* |
0.08 |
160 |
1 |
(0.6%) |
1* |
0.08 |
1.0 |
| Drug coverage |
160 |
126 |
(78.8%) |
- |
0.41 |
N/A |
N/A |
- |
N/A |
- |
|
| Antifilarial IgG1 |
161 |
94 |
(58.4%) |
122.7 |
182.5 |
161 |
85 |
52.8% |
99.0 |
146.9 |
0.11 |
| Antifilarial IgG4 |
161 |
125 |
(77.6%) |
104.8 |
155.4 |
161 |
117 |
72.7% |
102.1 |
215.6 |
0.052 |
|
*Microfilaria/ 20 μl among microfilaremic persons | |||||||||||
Washington et al. Filaria Journal 2004 3:3 doi:10.1186/1475-2883-3-3 |
|||||||||||